Search Results - "Roongruedee Chaiteerakij"

Refine Results
  1. 1

    Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis by Decharatanachart, Pakanat, Chaiteerakij, Roongruedee, Tiyarattanachai, Thodsawit, Treeprasertsuk, Sombat

    Published in BMC gastroenterology (06-01-2021)
    “…The gold standard for the diagnosis of liver fibrosis and nonalcoholic fatty liver disease (NAFLD) is liver biopsy. Various noninvasive modalities, e.g.,…”
    Get full text
    Journal Article
  2. 2

    COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand by Sirikalyanpaiboon, May, Ousirimaneechai, Krittin, Phannajit, Jeerath, Pitisuttithum, Panyavee, Jantarabenjakul, Watsamon, Chaiteerakij, Roongruedee, Paitoonpong, Leilani

    Published in BMC infectious diseases (22-11-2021)
    “…Abstract Background The COVID-19 vaccines provide renewed hope in the fight against the recent pandemic. To ensure widespread vaccination, it is crucial to…”
    Get full text
    Journal Article
  3. 3

    Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis by Wongjarupong, Nicha, Assavapongpaiboon, Buravej, Susantitaphong, Paweena, Cheungpasitporn, Wisit, Treeprasertsuk, Sombat, Rerknimitr, Rungsun, Chaiteerakij, Roongruedee

    Published in BMC gastroenterology (08-12-2017)
    “…Non-alcoholic fatty liver disease (NAFLD) has been recently identified as a risk factor of gastrointestinal tract cancers, especially hepatocellular carcinoma,…”
    Get full text
    Journal Article
  4. 4

    Exhaled volatile organic compounds for diagnosis of hepatocellular carcinoma by Sukaram, Thanikan, Tansawat, Rossarin, Apiparakoon, Terapap, Tiyarattanachai, Thodsawit, Marukatat, Sanparith, Rerknimitr, Rungsun, Chaiteerakij, Roongruedee

    Published in Scientific reports (29-03-2022)
    “…Volatile organic compounds (VOCs) profile for diagnosis and monitoring therapeutic response of hepatocellular carcinoma (HCC) has not been well studied. We…”
    Get full text
    Journal Article
  5. 5

    Changes in inflammatory cytokines, antioxidants and liver stiffness after chelation therapy in individuals with chronic lead poisoning by Teerasarntipan, Tongluk, Chaiteerakij, Roongruedee, Prueksapanich, Piyapan, Werawatganon, Duangporn

    Published in BMC gastroenterology (08-08-2020)
    “…Chronic exposure to lead causes lead to accumulate mainly in the liver. In vivo studies have shown that lead toxicity is related to alterations in the…”
    Get full text
    Journal Article
  6. 6

    Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis by Decharatanachart, Pakanat, Chaiteerakij, Roongruedee, Tiyarattanachai, Thodsawit, Treeprasertsuk, Sombat

    “…Background: The global prevalence of non-alcoholic fatty liver disease (NAFLD) continues to rise. Non-invasive diagnostic modalities including ultrasonography…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Aspirin use and the risk of cholangiocarcinoma by Choi, Jonggi, Ghoz, Hassan M., Peeraphatdit, Thoetchai, Baichoo, Esha, Addissie, Benyam D., Harmsen, William S., Therneau, Terry M., Olson, Janet E., Chaiteerakij, Roongruedee, Roberts, Lewis R.

    Published in Hepatology (Baltimore, Md.) (01-09-2016)
    “…Whether aspirin use is protective against cholangiocarcinoma (CCA) remains unclear. We determined the association between aspirin use and other risk factors…”
    Get full text
    Journal Article
  9. 9

    Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after Successful Treatment with Direct-Acting Antivirals by Rodprasert, Napas, Hongboontry, Tinn, Cherdchoochart, Chitchanok, Chaiteerakij, Roongruedee

    Published in Medicina (Kaunas, Lithuania) (01-03-2023)
    “…: Direct-acting antivirals (DAAs) are highly effective for the treatment of chronic hepatitis C virus (HCV) infection, but the risk of liver-related events and…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study by Chaiteerakij, Roongruedee, Pan-Ngum, Wirichada, Poovorawan, Kittiyod, Soonthornworasiri, Ngamphol, Treeprasertsuk, Sombat, Phaosawasdi, Kamthorn

    Published in World journal of gastroenterology : WJG (21-10-2017)
    “…AIM To identify the potential risk factors of cholangiocarcinoma, we determined the characteristics of cholangiocarcinoma patients among 5 different regions of…”
    Get full text
    Journal Article
  13. 13

    Cost-Utility Analysis of Non-Contrast Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance in Cirrhosis by Decharatanachart, Pakanat, Pan-Ngum, Wirichada, Peeraphatdit, Thoetchai, Tanpowpong, Natthaporn, Tangkijvanich, Pisit, Treeprasertsuk, Sombat, Rerknimitr, Rungsun, Chaiteerakij, Roongruedee

    Published in Gut and liver (01-01-2024)
    “…Ultrasonography has a low sensitivity for detecting early-stage hepatocellular carcinoma (HCC) in cirrhotic patients. Non-contrast abbreviated magnetic…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study by Thanapirom, Kessarin, Treeprasertsuk, Sombat, Soonthornworasiri, Ngamphol, Poovorawan, Kittiyod, Chaiteerakij, Roongruedee, Komolmit, Piyawat, Phaosawasdi, Kamthorn, Pinzani, Massimo

    Published in BMC gastroenterology (28-01-2019)
    “…Acute liver failure (ALF) is uncommon but progresses rapidly with high mortality. We investigated the incidence, etiologies, outcomes, and predictive factors…”
    Get full text
    Journal Article
  20. 20